Coronary Artery Bypass Grafts Device Market By Technology (Off pump CABG, On pump CABG, Minimally invasive CABG), By Product (Cardiopulmonary Bypass Machines, Endoscopic Vessel Harvesting Systems, Heart Positioners, Tissue Stabilizer, Others), By End Users (Hospitals, Cardiac Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Coronary Artery Bypass Grafts Device Market

The coronary artery bypass graft devices market is likely to experience a significant growth rate of 3.7% from 2022-2032, rise in geriatric population and surge in prevalence of cardiac disorders. Coronary artery bypass graft (CABG) devices are medical tools and equipment used during the coronary artery bypass graft (CABG) surgical procedure to facilitate the bypass of blocked or narrowed coronary arteries. A coronary artery bypass graft (CABG) is a surgical procedure used to treat coronary artery disease, a condition in which the blood vessels that supply the heart muscle with oxygen and nutrients become blocked or narrowed. 

Key factors driving the growth of coronary artery bypass graft devices market owing to surge in geriatric population and rise in the global prevalence of cardiovascular disorders. The coronary artery bypass grafts device market has witnessed a significant surge in recent years, primarily driven by the escalating geriatric population worldwide. This demographic shift, characterized by an increasing number of elderly individuals, has led to a substantial rise in the prevalence of cardiovascular diseases, particularly coronary artery disease (CAD). As individuals age, their risk of developing CAD and related complications, such as blocked or narrowed coronary arteries, significantly increases. For instance, according to a 2023 study by National Library of Medicine, older adults aged 70 and above years had a higher prevalence of uncontrolled heart diseases compared to middle-aged adults and young-olds age groups. As individuals age, their risk of developing coronary artery disease and related complications, such as blocked or narrowed coronary arteries, significantly increases. This has created a growing demand for coronary artery bypass grafts procedures, as they remain one of the most effective treatment options for patients with severe coronary artery disease. Thus, the rise in the geriatric population is expected o drive the growth of the market.

The global prevalence of cardiovascular disorders has witnessed a significant and alarming rise in recent years, and this surge has emerged as a major driving force behind the growth of the coronary artery bypass grafts device market. For instance, according to report by U.S. Department of Health & Human Services, in 2021 the prevalence of coronary artery disease was estimated to be 5% in U.S. Cardiovascular disorders, encompassing a range of conditions such as coronary artery disease, heart attacks, and congestive heart failure, have become increasingly prevalent due to various factors including sedentary lifestyles, unhealthy dietary habits, smoking, and the aging population. As a result, there has been a growing demand for coronary artery bypass graft devices, as they play a pivotal role in the management and treatment of coronary artery disease. 

However, the high cost of coronary artery bypass graft devices represents a significant restraint for the coronary artery bypass grafts device market. The cost associated with the devices used in these procedures can be a substantial barrier to access for both patients and healthcare providers. Moreover, rise in awareness about heart health has presented a significant growth opportunity for the coronary artery bypass grafts (CABG) device market. As global populations continue to grapple with the increasing prevalence of cardiovascular diseases, individuals, healthcare providers, and governments are becoming more cognizant of the importance of heart health. This heightened awareness is driving a surge in demand for advanced medical interventions, including CABG procedures, which are commonly employed to treat coronary artery disease.

The coronary artery bypass graft devices market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into off-pump, on-pump, and minimally invasive CABG. By product, the market is classified into cardiopulmonary bypass machines, endoscopic vessel harvesting systems, heart positioners, tissue stabilizer and others. By end user, the market is divided into hospitals, cardiology centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East & Africa).

The key players profiled in the study include Medtronic, Baxter International Inc, Terumo Corporation, Teleflex Incorporated, Peters Surgical Group, Getinge AB, Genesee Biomedical Inc, Transonic Systems Inc., Saphena Medical, Inc. and Condor MedTec GmbH.

Key Market Insights 

•    On the basis of technology, the on-pump segment was the highest contributor to the market in 2022. However, off pump segment is expected to register the fastest growth during the forecasted period.

•    On the basis of product, the tissue stabilizer was the highest contributor to the market in 2022.

•    On the basis of end user, the hospital segment was the highest contributor to the market in 2022.

•    On the basis of region, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. 

 

Overview

The coronary artery bypass grafts device market was valued at $959.27 million in 2022 and is estimated to reach $1,382.30 million by 2032, exhibiting a CAGR of 3.7% from 2023 to 2032.  The global coronary artery bypass grafts device market was valued at $0.96 billion in 2022, and is projected to reach $1.38 billion by 2032, growing at a CAGR of 3.7% from 2023 to 2032.

Coronary artery bypass graft (CABG) device plays an important role in the surgical treatment of coronary artery disease. Coronary artery disease is a condition where the blood vessels supplying blood to the heart muscles become narrowed or blocked due to the buildup of plaque. Coronary artery bypass graft is a surgical procedure which is carried out to restore adequate blood flow to the heart muscles by bypassing the blocked or narrowed coronary arteries with healthy blood vessels. In general, on-pump and off-pump are the two types of CABG surgical procedures with the difference being the use of a cardiopulmonary bypass circuit and an arrested heart to operate during an on-pump coronary artery bypass graft. On the other hand, during off-pump coronary artery bypass graft, the surgeons operates on the beating heat.  

The key factors driving the growth of the coronary artery bypass graft devices market are rise in geriatric population as they have the risk of developing coronary heart disease (CHD) and related conditions such as atherosclerosis increases significantly with age. Furthermore, surge in prevalence of coronary heart diseases owing to lifestyle changes, sedentary habits, unhealthy diets, and increase in stress levels is also expected to drive the growth of the market. As people age, their risk of developing coronary artery disease (CAD) and related cardiac issues significantly increases. Coronary artery disease is a prevalent condition worldwide, characterized by the accumulation of plaque in the coronary arteries, leading to reduced blood flow to the heart muscle. For instance, according to a 2023 report by American Heart Association, it was estimated that the average age at the first heart attack was 65.6 years for males and 72.0 years for females. 

Coronary artery bypass grafting is a crucial surgical intervention used to treat severe coronary artery disease. It involves the creation of alternative blood pathways by grafting healthy blood vessels from other parts of the body to bypass the blocked or narrowed coronary arteries, thereby restoring proper blood flow to the heart. As the geriatric population is more prone to coronary artery disease and related cardiovascular problems, the demand for coronary artery bypass graft procedures and associated devices has surged. Furthermore, the elderly often have multiple comorbidities, making them ideal candidates for coronary artery bypass graft surgeries as compared to more invasive or complex procedures. In conclusion, the escalating geriatric population, with its higher susceptibility to coronary artery disease, has become a pivotal driver for the growth of the coronary artery bypass graft devices market.   

In addition, surge in prevalence of coronary heart disease is expected to act as a significant driver for the coronary artery bypass graft devices market. The bypass restores the blood flow to the ischemic myocardium which, in turn, restores function, viability, and relieves anginal symptoms. The global burden of coronary heart disease has been on the rise, primarily attributed to lifestyle factors such as sedentary lifestyles, unhealthy diets, and increasing rates of obesity. For instance, according to a 2023 report by U.S. National library of medicine, it was estimated that globally almost 400,000 coronary artery bypass grafting surgeries are performed each year making it the most commonly performed major surgical procedure. Thus, the surge in the prevalence of coronary heart disease is expected to drive the growth of the coronary artery bypass graft devices market.   

However, high cost of procedures might act as restraint for the coronary artery bypass graft devices market. The high cost of coronary artery bypass graft surgery makes it less accessible to individuals without adequate health insurance coverage. The cost of devices, hospital stays, and post-operative care be a significant financial burden for patients.  

The coronary artery bypass graft devices market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into off-pump, on-pump, and minimally invasive CABG. By product, the market is classified into cardiopulmonary bypass machines, endoscopic vessel harvesting systems, heart positioners, tissue stabilizer and others. By end user, the market is divided into hospitals, cardiac centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global coronary artery bypass graft devices market are Medtronic, Baxter International Inc, Terumo Corporation, Teleflex Incorporated, Peters Surgical Group, Getinge AB, Genesee Biomedical Inc, Transonic Systems Inc., Saphena Medical, Inc. and Condor MedTec GmbH.

Key Benefits for Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary artery bypass grafts device market analysis from 2022 to 2032 to identify the prevailing coronary artery bypass grafts device market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the coronary artery bypass grafts device market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global coronary artery bypass grafts device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

● Technology Trend Analysis

● Patient/epidemiology data at country, region, global level

● Regulatory Guidelines

● Additional company profiles with specific to client's interest

● Additional country or region analysis- market size and forecast

● Expanded list for Company Profiles

● Historic market data

● SWOT Analysis

Key Market Segments

○ Livanova, Pl

Scope of Coronary Artery Bypass Grafts Device Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Low bargaining power of suppliers

3.3.2. Low threat of new entrants

3.3.3. Low threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. Low bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Surge in prevalence of cardiovascular diseases.

3.4.1.2. Unhealthy diet and modern sedentary lifestyle.

3.4.1.3. Rise in geriatric population.

3.4.2. Restraints

3.4.2.1. High cost of coronary artery bypass graft devices.

3.4.3. Opportunities

3.4.3.1. Rise in awareness about heart health

4.1. Overview

4.1.1. Market size and forecast

4.2. Off pump CABG

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. On pump CABG

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Minimally invasive CABG

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Cardiopulmonary Bypass Machines

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Endoscopic Vessel Harvesting Systems

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Heart Positioners

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Tissue Stabilizer

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

5.6. Others

5.6.1. Key market trends, growth factors and opportunities

5.6.2. Market size and forecast, by region

5.6.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Cardiac Centers

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by Technology

7.2.3. Market size and forecast, by Product

7.2.4. Market size and forecast, by End Users

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by Technology

7.2.5.1.2. Market size and forecast, by Product

7.2.5.1.3. Market size and forecast, by End Users

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by Technology

7.2.5.2.2. Market size and forecast, by Product

7.2.5.2.3. Market size and forecast, by End Users

7.2.5.3. Mexico

7.2.5.3.1. Market size and forecast, by Technology

7.2.5.3.2. Market size and forecast, by Product

7.2.5.3.3. Market size and forecast, by End Users

7.3. Europe

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by Technology

7.3.3. Market size and forecast, by Product

7.3.4. Market size and forecast, by End Users

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by Technology

7.3.5.1.2. Market size and forecast, by Product

7.3.5.1.3. Market size and forecast, by End Users

7.3.5.2. France

7.3.5.2.1. Market size and forecast, by Technology

7.3.5.2.2. Market size and forecast, by Product

7.3.5.2.3. Market size and forecast, by End Users

7.3.5.3. UK

7.3.5.3.1. Market size and forecast, by Technology

7.3.5.3.2. Market size and forecast, by Product

7.3.5.3.3. Market size and forecast, by End Users

7.3.5.4. Italy

7.3.5.4.1. Market size and forecast, by Technology

7.3.5.4.2. Market size and forecast, by Product

7.3.5.4.3. Market size and forecast, by End Users

7.3.5.5. Spain

7.3.5.5.1. Market size and forecast, by Technology

7.3.5.5.2. Market size and forecast, by Product

7.3.5.5.3. Market size and forecast, by End Users

7.3.5.6. Rest of Europe

7.3.5.6.1. Market size and forecast, by Technology

7.3.5.6.2. Market size and forecast, by Product

7.3.5.6.3. Market size and forecast, by End Users

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by Technology

7.4.3. Market size and forecast, by Product

7.4.4. Market size and forecast, by End Users

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by Technology

7.4.5.1.2. Market size and forecast, by Product

7.4.5.1.3. Market size and forecast, by End Users

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by Technology

7.4.5.2.2. Market size and forecast, by Product

7.4.5.2.3. Market size and forecast, by End Users

7.4.5.3. India

7.4.5.3.1. Market size and forecast, by Technology

7.4.5.3.2. Market size and forecast, by Product

7.4.5.3.3. Market size and forecast, by End Users

7.4.5.4. Australia

7.4.5.4.1. Market size and forecast, by Technology

7.4.5.4.2. Market size and forecast, by Product

7.4.5.4.3. Market size and forecast, by End Users

7.4.5.5. South Korea

7.4.5.5.1. Market size and forecast, by Technology

7.4.5.5.2. Market size and forecast, by Product

7.4.5.5.3. Market size and forecast, by End Users

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Market size and forecast, by Technology

7.4.5.6.2. Market size and forecast, by Product

7.4.5.6.3. Market size and forecast, by End Users

7.5. LAMEA

7.5.1. Key market trends, growth factors and opportunities

7.5.2. Market size and forecast, by Technology

7.5.3. Market size and forecast, by Product

7.5.4. Market size and forecast, by End Users

7.5.5. Market size and forecast, by country

7.5.5.1. Latin America

7.5.5.1.1. Market size and forecast, by Technology

7.5.5.1.2. Market size and forecast, by Product

7.5.5.1.3. Market size and forecast, by End Users

7.5.5.2. Middle East And Africa

7.5.5.2.1. Market size and forecast, by Technology

7.5.5.2.2. Market size and forecast, by Product

7.5.5.2.3. Market size and forecast, by End Users

8.1. Introduction

8.2. Top winning strategies

8.3. Product mapping of top 10 player

8.4. Competitive dashboard

8.5. Competitive heatmap

8.6. Top player positioning, 2022

9.1. Medtronic

9.1.1. Company overview

9.1.2. Key executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.2. Baxter International Inc.

9.2.1. Company overview

9.2.2. Key executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.3. Terumo Corporation

9.3.1. Company overview

9.3.2. Key executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.4. Peters Surgical Group

9.4.1. Company overview

9.4.2. Key executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.5. Getinge AB

9.5.1. Company overview

9.5.2. Key executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.5.6. Business performance

9.6. Genesee Biomedical Inc

9.6.1. Company overview

9.6.2. Key executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.7. Transonic Systems Inc.

9.7.1. Company overview

9.7.2. Key executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.8. Livanova, Plc

9.8.1. Company overview

9.8.2. Key executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.8.7. Key strategic moves and developments

9.9. Condor MedTec GmbH

9.9.1. Company overview

9.9.2. Key executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.10. Saphena Medical, Inc.

9.10.1. Company overview

9.10.2. Key executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 02. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OFF PUMP CABG, BY REGION, 2022-2032 ($MILLION)

TABLE 03. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ON PUMP CABG, BY REGION, 2022-2032 ($MILLION)

TABLE 04. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR MINIMALLY INVASIVE CABG, BY REGION, 2022-2032 ($MILLION)

TABLE 05. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 06. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIOPULMONARY BYPASS MACHINES, BY REGION, 2022-2032 ($MILLION)

TABLE 07. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ENDOSCOPIC VESSEL HARVESTING SYSTEMS, BY REGION, 2022-2032 ($MILLION)

TABLE 08. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HEART POSITIONERS, BY REGION, 2022-2032 ($MILLION)

TABLE 09. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR TISSUE STABILIZER, BY REGION, 2022-2032 ($MILLION)

TABLE 10. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 12. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)

TABLE 13. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIAC CENTERS, BY REGION, 2022-2032 ($MILLION)

TABLE 14. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 15. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 16. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 17. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 18. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 19. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 20. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 21. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 22. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 23. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 24. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 25. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 26. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 27. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 28. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 29. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 30. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 31. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 32. EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 33. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 34. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 35. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 36. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 37. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 38. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 39. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 40. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 41. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 42. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 43. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 44. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 45. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 46. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 47. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 48. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 49. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 50. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 51. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 52. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 53. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 54. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 55. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 56. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 58. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 59. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 60. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 61. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 62. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 63. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 64. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 65. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 66. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 67. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 68. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 73. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 74. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 75. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 76. LAMEA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 77. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 78. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 79. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 80. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)

TABLE 81. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 82. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022-2032 ($MILLION)

TABLE 83. MEDTRONIC: KEY EXECUTIVES

TABLE 84. MEDTRONIC: COMPANY SNAPSHOT

TABLE 85. MEDTRONIC: PRODUCT SEGMENTS

TABLE 86. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 87. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES

TABLE 88. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 89. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS

TABLE 90. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 91. TERUMO CORPORATION: KEY EXECUTIVES

TABLE 92. TERUMO CORPORATION: COMPANY SNAPSHOT

TABLE 93. TERUMO CORPORATION: PRODUCT SEGMENTS

TABLE 94. TERUMO CORPORATION: PRODUCT PORTFOLIO

TABLE 95. PETERS SURGICAL GROUP: KEY EXECUTIVES

TABLE 96. PETERS SURGICAL GROUP: COMPANY SNAPSHOT

TABLE 97. PETERS SURGICAL GROUP: PRODUCT SEGMENTS

TABLE 98. PETERS SURGICAL GROUP: PRODUCT PORTFOLIO

TABLE 99. GETINGE AB: KEY EXECUTIVES

TABLE 100. GETINGE AB: COMPANY SNAPSHOT

TABLE 101. GETINGE AB: PRODUCT SEGMENTS

TABLE 102. GETINGE AB: PRODUCT PORTFOLIO

TABLE 103. GENESEE BIOMEDICAL INC: KEY EXECUTIVES

TABLE 104. GENESEE BIOMEDICAL INC: COMPANY SNAPSHOT

TABLE 105. GENESEE BIOMEDICAL INC: PRODUCT SEGMENTS

TABLE 106. GENESEE BIOMEDICAL INC: PRODUCT PORTFOLIO

TABLE 107. TRANSONIC SYSTEMS INC.: KEY EXECUTIVES

TABLE 108. TRANSONIC SYSTEMS INC.: COMPANY SNAPSHOT

TABLE 109. TRANSONIC SYSTEMS INC.: PRODUCT SEGMENTS

TABLE 110. TRANSONIC SYSTEMS INC.: PRODUCT PORTFOLIO

TABLE 111. LIVANOVA, PLC: KEY EXECUTIVES

TABLE 112. LIVANOVA, PLC: COMPANY SNAPSHOT

TABLE 113. LIVANOVA, PLC: PRODUCT SEGMENTS

TABLE 114. LIVANOVA, PLC: PRODUCT PORTFOLIO

TABLE 115. LIVANOVA, PLC: KEY STRATERGIES

TABLE 116. CONDOR MEDTEC GMBH: KEY EXECUTIVES

TABLE 117. CONDOR MEDTEC GMBH: COMPANY SNAPSHOT

TABLE 118. CONDOR MEDTEC GMBH: PRODUCT SEGMENTS

TABLE 119. CONDOR MEDTEC GMBH: PRODUCT PORTFOLIO

TABLE 120. SAPHENA MEDICAL, INC.: KEY EXECUTIVES

TABLE 121. SAPHENA MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 122. SAPHENA MEDICAL, INC.: PRODUCT SEGMENTS

TABLE 123. SAPHENA MEDICAL, INC.: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET,2022-2032

FIGURE 03. TOP IMPACTING FACTORS IN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET (2020 TO 2022)

FIGURE 04. TOP INVESTMENT POCKETS IN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET (2023-2032)

FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 06. LOW THREAT OF NEW ENTRANTS

FIGURE 07. LOW THREAT OF SUBSTITUTES

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. LOW BARGAINING POWER OF BUYERS

FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY, 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OFF PUMP CABG, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ON PUMP CABG, BY COUNTRY 2022 AND 2032(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR MINIMALLY INVASIVE CABG, BY COUNTRY 2022 AND 2032(%)

FIGURE 15. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT, 2022 AND 2032(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIOPULMONARY BYPASS MACHINES, BY COUNTRY 2022 AND 2032(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR ENDOSCOPIC VESSEL HARVESTING SYSTEMS, BY COUNTRY 2022 AND 2032(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HEART POSITIONERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR TISSUE STABILIZER, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 21. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS, 2022 AND 2032(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR CARDIAC CENTERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 25. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET BY REGION, 2022 AND 2032(%)

FIGURE 26. U.S. CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 27. CANADA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 28. MEXICO CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 29. GERMANY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 30. FRANCE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 31. UK CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 32. ITALY CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 33. SPAIN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 34. REST OF EUROPE CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 35. JAPAN CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 36. CHINA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 37. INDIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 38. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 39. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 40. REST OF ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 41. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 42. MIDDLE EAST AND AFRICA CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, 2022-2032 ($MILLION)

FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2022-2023)

FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2023)

FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2022-2023)

FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 47. COMPETITIVE DASHBOARD

FIGURE 48. COMPETITIVE HEATMAP: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET

FIGURE 49. TOP PLAYER POSITIONING, 2022

FIGURE 50. MEDTRONIC: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 51. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 52. MEDTRONIC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 53. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 54. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 55. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 56. TERUMO CORPORATION: NET SALES, 2021-2023 ($MILLION)

FIGURE 57. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)

FIGURE 58. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2023 (%)

FIGURE 59. GETINGE AB: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 60. GETINGE AB: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 61. GETINGE AB: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 62. LIVANOVA, PLC: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 63. LIVANOVA, PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 64. LIVANOVA, PLC: REVENUE SHARE BY REGION, 2022 (%